Assignee
PREC BIOLOGICS INC
US·21 granted patents·9 pending applications·42 citations·filing 2013–2025
Top patents by PatentIndex Score
30 records- 0197US11952429B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersPREC BIOLOGICS INC·Filed 2022·Granted Apr 9, 2024·2 cites·22 claims
- 0292US12344676B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersPREC BIOLOGICS INC·Filed 2024·Granted Jul 1, 2025·0 cites·7 claims
- 0392US11401341B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersPREC BIOLOGICS INC·Filed 2020·Granted Aug 2, 2022·2 cites·20 claims
- 0492US9718866B2Colon and pancreas cancer peptidomimeticsPREC BIOLOGICS INC·Filed 2015·Granted Aug 1, 2017·6 cites·20 claims
- 0590US11279768B1Anti-cancer antibodies, combination therapies, and uses thereofPREC BIOLOGICS INC·Filed 2016·Granted Mar 22, 2022·6 cites·20 claims
- 0690US10023650B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersPREC BIOLOGICS INC·Filed 2016·Granted Jul 17, 2018·5 cites·20 claims
- 0788US9605077B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersPREC BIOLOGICS INC·Filed 2015·Granted Mar 28, 2017·5 cites·18 claims
- 0886US10533040B2Colon and pancreas cancer peptidomimeticsPREC BIOLOGICS INC·Filed 2017·Granted Jan 14, 2020·2 cites·9 claims
- 0986US2026015432A1Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersPREC BIOLOGICS INC·Filed 2025·Application pending·0 cites
- 1085US12460013B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersPREC BIOLOGICS INC·Filed 2022·Granted Nov 4, 2025·0 cites·12 claims
- 1185US11001641B2Monoclonal antibody therapy for pancreas cancerPREC BIOLOGICS INC·Filed 2018·Granted May 11, 2021·1 cites·19 claims
- 1285US10364295B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersPREC BIOLOGICS INC·Filed 2017·Granted Jul 30, 2019·3 cites·19 claims
- 1385US9592290B2Monoclonal antibody therapy for pancreas cancerPREC BIOLOGICS INC·Filed 2014·Granted Mar 14, 2017·5 cites·11 claims
- 1484US11572413B2Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersPREC BIOLOGICS INC·Filed 2019·Granted Feb 7, 2023·1 cites·14 claims
- 1579US10689443B2Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancerPREC BIOLOGICS INC·Filed 2018·Granted Jun 23, 2020·1 cites·18 claims
- 1677US11767367B2Monoclonal antibody neo-201 for the treatment of human carcinomasPREC BIOLOGICS INC·Filed 2018·Granted Sep 26, 2023·1 cites·19 claims
- 1776US12454560B2Colon and pancreas cancer peptidomimeticsPREC BIOLOGICS INC·Filed 2021·Granted Oct 28, 2025·0 cites·8 claims
- 1875US9938344B2Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancerPREC BIOLOGICS INC·Filed 2013·Granted Apr 10, 2018·2 cites·13 claims
- 1974US11078245B2Colon and pancreas cancer peptidomimeticsPREC BIOLOGICS INC·Filed 2019·Granted Aug 3, 2021·0 cites·20 claims
- 2073US2024101702A1Monoclonal antibody neo-201 for the treatment of human carcinomasPREC BIOLOGICS INC·Filed 2023·Application pending·0 cites
- 2171US2024400714A1Methods and compositions for targeting treg cellsPREC BIOLOGICS INC·Filed 2024·Application pending·0 cites
- 2269US2018346594A1Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancersPREC BIOLOGICS INC·Filed 2018·Application pending·0 cites
- 2367US11505604B2Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancerPREC BIOLOGICS INC·Filed 2020·Granted Nov 22, 2022·0 cites·20 claims
- 2464US11345733B2Colon and pancreas cancer specific antigens and antibodiesPREC BIOLOGICS INC·Filed 2018·Granted May 31, 2022·0 cites·19 claims
- 2564US2023032624A1Colon and pancreas cancer specific antigens and antibodiesPREC BIOLOGICS INC·Filed 2022·Application pending·0 cites
- 2659US2026083840A1Methods for ablating myeloid derived suppressor cells using neo-201 antibodyPREC BIOLOGICS INC·Filed 2023·Application pending·0 cites
- 2759US2017210816A1Monoclonal antibody therapy for pancreas cancerPREC BIOLOGICS INC·Filed 2017·Application pending·0 cites
- 2858US12037410B2Methods and compositions for targeting Treg cellsPREC BIOLOGICS INC·Filed 2019·Granted Jul 16, 2024·0 cites·12 claims
- 2953US2024384003A1Methods and compositions for treating hematological malignanciesPREC BIOLOGICS INC·Filed 2022·Application pending·0 cites
- 3049US2025326859A1Anti-cancer antibodies, combination therapies, and uses thereofPREC BIOLOGICS INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when PREC BIOLOGICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →